Nebula Research & Development LLC Purchases 15,406 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Nebula Research & Development LLC raised its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 182.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,867 shares of the medical device company's stock after acquiring an additional 15,406 shares during the quarter. Nebula Research & Development LLC's holdings in Cooper Companies were worth $2,194,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Barclays PLC boosted its holdings in shares of Cooper Companies by 0.7% during the third quarter. Barclays PLC now owns 462,947 shares of the medical device company's stock worth $51,082,000 after acquiring an additional 3,070 shares during the period. Anchor Investment Management LLC increased its position in Cooper Companies by 1,029.2% during the 3rd quarter. Anchor Investment Management LLC now owns 1,084 shares of the medical device company's stock worth $120,000 after buying an additional 988 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Cooper Companies during the third quarter worth $1,150,000. Tidal Investments LLC grew its stake in shares of Cooper Companies by 7.8% in the third quarter. Tidal Investments LLC now owns 14,369 shares of the medical device company's stock valued at $1,585,000 after acquiring an additional 1,043 shares in the last quarter. Finally, Synovus Financial Corp increased its position in Cooper Companies by 18.8% during the third quarter. Synovus Financial Corp now owns 31,568 shares of the medical device company's stock worth $3,483,000 after acquiring an additional 4,987 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Up 0.5 %

Shares of Cooper Companies stock traded up $0.38 on Tuesday, hitting $82.23. 1,156,728 shares of the company's stock traded hands, compared to its average volume of 1,887,446. The company has a market capitalization of $16.44 billion, a price-to-earnings ratio of 42.17, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a fifty day moving average of $82.04 and a two-hundred day moving average of $92.41. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Robert W. Baird decreased their target price on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Finally, Citigroup cut their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.